MK-4082

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4082, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002) [Phase 1]